MedTrace Logo

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients

NCT00699868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2012-06-04

No results posted yet for this study

Summary

This prospective study evaluate the immune status of patients admitted in ICU.CMV remains dormant in the body, but in people with immune deficiency, CMV could reactivate and cause life-threatening pneumonia.

Conditions

  • Cytomegalovirus Infection

Interventions

OTHER

Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings

Sampling of blood

OTHER

Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings

Sampling of blood

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • Jean-Marie FOREL, MD · Assistance Publique des Hôpitaux de Marseille

Study Design

Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-01-31
Completion
2011-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00699868 on ClinicalTrials.gov